treonam resistance," he says. However, although AztraZeneca is conducting clinical trials to evaluate ceftazidime combined with NXL-104, the combination of NXL-104 and aztreonam is not being developed commercially, according to Livermore. Officials at the Food and Drug Administration (FDA) in January issued detailed guidance for the performance of nucleic acid-based in vitro diagnostic devices for testing clinical specimens suspected of containing methicillin-resistant Staphylococcus aureus (MRSA). Although agency officials say the guidance can be used to support Class II submissions for such devices, they emphasize that the current documents are not meant to establish "legally enforceable responsibilities." Meanwhile, recent research findings help to explain why S. aureus is such an effective pathogen of humans. These bacteria carry a receptor that recognizes portions of the hemoglobin protein that are peculiar to humans, according to Erik Skaar and his collaborators at Vanderbilt University in Nashville, Tenn. Thus, the pathogen is particularly adept at acquiring the iron that it needs from specific human protein molecules that sequester it. Details appear in the December 16, 2010 Cell Host & Microbe (8:544 -550) .
year, according to Caroline Smith DeWaal, who is Food Safety Director for the Center for Science in the Public Interest, a consumer advocacy organization in Washington, D.C. Recent high-profile outbreaks of foodborne illnesses helped to build broad and bipartisan support for the new law, she says. Its provisions are directed mainly at FDA, in part because public concerns about food safety focus there during outbreaks. The U.S. Department of Agriculture (USDA) shares federal responsibility for food safety, particularly through its inspections of meat and poultry.
The new law, which "marks an overall improvement," contains several important provisions, says Michael Doyle, Director of the Center for Food Safety at the University of Georgia in Griffin. For example, giving FDA authority to issue "mandatory food recalls is new," as is extending agency authority over food imports.
Another provision that is "new and important is that all companies will need to have food safety plans in place, except for those that are waived," he adds, referring to smaller companies that operate only locally or with low volumes of products.
Some changes that were incorporated into the new law reflect a "shift to risk analysis and what's the biological basis of adverse effects" that took shape during the past decade, says Robert L. Buchanan, who directs the Center for Food Safety and Security Systems at the University of Maryland, College Park. An important component of this approach is "risk ranking," which entails figuring out "what foods present the most risk." Complicating any effort to bring better scientific understanding to these analytic challenges, however, is the way the public seems to treat food risks, he says. "It's fascinating; we seem to feel differently about food than anything else. It's almost sacred-either safe or unsafe-whereas with drugs, we recognize [gradations of] risk."
Even before President Obama signed FMSA, some members of Congress were vowing to block its provisions by curbing FDA funds. "One of the big hurdles is that it will cost $1.4 billion to implement FMSA," Doyle says. Earlier versions of the legislation included user fees, but they were discarded along the way to enactment. "If FDA wants to hire 2,000 inspectors, it will require a considerable appropriation," he says. "Time will tell." 
Microbes in Unexpected Places or with Unexpected Activities
Here are several recent examples of microbes being found in unexpected niches or undertaking unexpected activities:
• Rocks within the gabbroic layer of the Earth, which lies above the mantle but is more than 1 km below sea level, provide a niche for a poorly diverse microbial community, much of it devoted to degrading hydrocarbons, according to Stephen Giovannoni of Oregon State University, Corvallis, and collaborators there and at several other institutions. Details appear in the November 5, 2010, PLoS ONE.
• When fed to mice, nonpathogenic strains of Clostridium bacteria can stimulate regulatory T cells in the gut, in turn suppressing allergies and autoimmune diseases of the host, according to Kenya Honda of the University of Tokyo and collaborators. Details appear online 23 December 2010 and in print on 21 January 2011 in Science (331: 337-341).
• A strain of bacteria from the mud of Mono Lake, California, appears to thrive on arsenic, perhaps substituting it for phosphate, according to Felisa Wolfe-Simon at the U.S. Geological Survey in Menlo Park, Calif., and her collaborators. Details appear online in the 3 December 2010 Science. (These findings are stirring considerable controversy in the scientific blogosphere.)
